BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32498921)

  • 1. DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker.
    Scully PR; Morris E; Patel KP; Treibel TA; Burniston M; Klotz E; Newton JD; Sabharwal N; Kelion A; Manisty C; Kennon S; Ozkor M; Mullen M; Hartman N; Elliott PM; Pugliese F; Hawkins PN; Moon JC; Menezes LJ
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1353-1363. PubMed ID: 32498921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative
    Caobelli F; Braun M; Haaf P; Wild D; Zellweger MJ
    J Nucl Cardiol; 2020 Oct; 27(5):1456-1463. PubMed ID: 31538322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
    Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
    Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimized imaging protocol for [
    Schatka I; Bingel A; Schau F; Bluemel S; Messroghli DR; Frumkin D; Knebel F; Diekmann SM; Elsanhoury A; Tschöpe C; Hahn K; Amthauer H; Rogasch JMM; Wetz C
    J Nucl Cardiol; 2021 Dec; 28(6):2483-2496. PubMed ID: 34331215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis.
    Ungericht M; Groaz V; Messner M; Schuetz T; Brunelli L; Zaruba MM; Lener D; Stocker E; Bauer A; Kroiss AS; Mayr A; Röcken C; Poelzl G
    Amyloid; 2024 Mar; 31(1):22-31. PubMed ID: 37530216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of [
    Caobelli F; Gözlügöl N; Bakula A; Rominger A; Schepers R; Stortecky S; Hunziker Munsch L; Dobner S; Gräni C
    J Nucl Med; 2024 Jun; 65(6):944-951. PubMed ID: 38724281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
    Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of
    Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
    Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy.
    Rettl R; Wollenweber T; Duca F; Binder C; Cherouny B; Dachs TM; Camuz Ligios L; Schrutka L; Dalos D; Beitzke D; Loewe C; Badr Eslam R; Kastner J; Hacker M; Bonderman D
    Eur Heart J Cardiovasc Imaging; 2023 Jul; 24(8):1019-1030. PubMed ID: 36881774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Quantification of Myocardial Amyloid Deposits in Patients with Suspected Transthyretin-Related Amyloidosis (ATTR).
    Wollenweber T; Rettl R; Kretschmer-Chott E; Rasul S; Kulterer O; Rainer E; Raidl M; Schaffarich MP; Matschitsch S; Stadler M; Traub-Weidinger T; Beiztke D; Loewe C; Duca F; Mascherbauer J; Bonderman D; Hacker M
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33120935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPECT/CT SUV-based metrics: A promising diagnostic tool in classifying patients with suspected transthyretin cardiac amyloidosis among the different Perugini grades?
    Koukouraki S; Kapsoritakis N; Bourogianni O; Stathaki M; Zaganas I; Patrianakos A; Plevritaki A; Korela D; Marketou M; Foukarakis E
    Hell J Nucl Med; 2023; 26(3):172-180. PubMed ID: 38085832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative single photon emission computed tomography derived standardized uptake values on 99mTc-PYP scan in patients with suspected ATTR cardiac amyloidosis.
    Avalon JC; Fuqua J; Deskins S; Miller T; Conte J; Martin D; Marano G; Yanamala N; Mills J; Bianco C; Patel B; Seetharam K; Raylman R; Sengupta PP; Hamirani YS
    J Nucl Cardiol; 2023 Feb; 30(1):127-139. PubMed ID: 35655113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications.
    Lee J; Kim K; Choi JO; Kim SJ; Jeon ES; Choi JY
    Medicine (Baltimore); 2020 Jan; 99(4):e18905. PubMed ID: 31977903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac transthyretin amyloidosis
    Löfbacka V; Axelsson J; Pilebro B; Suhr OB; Lindqvist P; Sundström T
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1822-1832. PubMed ID: 33367948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative
    Kessler L; Fragoso Costa P; Kersting D; Jentzen W; Weber M; Lüdike P; Carpinteiro A; Oubari S; Hagenacker T; Thimm A; Rassaf T; Herrmann K; Papathanasiou M; Rischpler C
    J Nucl Cardiol; 2023 Feb; 30(1):101-111. PubMed ID: 35562639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters.
    Wollenweber T; Rettl R; Kretschmer-Chott E; Rasul S; Kulterer OC; Kluge K; Duca F; Bonderman D; Hacker M; Traub-Weidinger T
    J Nucl Cardiol; 2023 Aug; 30(4):1363-1371. PubMed ID: 36513919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients.
    Scully PR; Patel KP; Saberwal B; Klotz E; Augusto JB; Thornton GD; Hughes RK; Manisty C; Lloyd G; Newton JD; Sabharwal N; Kelion A; Kennon S; Ozkor M; Mullen M; Hartman N; Cavalcante JL; Menezes LJ; Hawkins PN; Treibel TA; Moon JC; Pugliese F
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2177-2189. PubMed ID: 32771574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: Imaging at 1 vs 3 hours and planar vs SPECT/CT.
    Sperry BW; Burgett E; Bybee KA; McGhie AI; O'Keefe JH; Saeed IM; Thompson RC; Bateman TM
    J Nucl Cardiol; 2020 Oct; 27(5):1802-1807. PubMed ID: 32415627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.